Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens

Arthritis and Rheumatism

Volumn 43, Issue 5, 2000, Pages 1062-1067

  Artlett, Carol M ^a,b   Cox, Lori A ^a   Jimenez, Sergio A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MICROCHIMERISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; CHIMERA; COHORT STUDIES; DNA; FEMALE; GENOTYPE; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC;

EID: 0034091314     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200005)43:5<1062::AID-ANR16>3.0.CO;2-P     Document Type: Article

References (36)

1. Siimes MA, Johansson E, Rapola J. Scleroderma-like graft-versus-host disease as late consequence of bone marrow grafting. Lancet 1977;2:831-2.
2. Hood AF, Soter NA, Rappaport J, Gigli I. Graft-versus-host reaction: cutaneous manifestations following bone marrow transplantation. Arch Dermatol 1977;113:1087-91.
3. Furst DE, Clements PJ, Graze P, Gale R, Roberts N. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979;22: 904-10.
4. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwolil AA, Deisscroth AB, Scleroderma, Sjögren-like syndrome and chronic graft-versus-host disease. Ann Intern Med 1977;87:707-9.
5. Bos GMJ, Majoor GD, Slaaf DW, van de Gaar MJ, Weijmer-van Velzen JS, van Breda Vriesman PJ. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models. Transplant Proc 1989;21:3262-3.
6. Chosidow O, Bagot M, Vernant J-P, Roujeau JC, Cordonnier C, Kuentz M, et al. Sclerodermatous chronic graft-versus-host disease. J Am Acad Dermatol 1992;26:49-55.
7. Artlett CM, Smith JB, Jimenez SA. New perspectives on the etiology of systemic sclerosis. Mol Med Today 1999;5:74-8.
8. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
9. Lambert IA, Switters AJ, Janossy G. Lymphoid infiltrates in skin in graft-versus-host disease. Lancet 1981;2:1352.
10. Jimenez SA. Cellular immune dysfunction and the pathogenesis of scleroderma. Semin Arthritis Rheum 1983;13 Suppl 1:104-13.
11. Kahaleh MB, LeRoy EC. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989;110:446-50.
12. Fagundus DM, LeRoy EC. Cytokines and systemic sclerosis. Clin Dermatol 1994;12:407-17.
13. Postlethwaite AE. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1993;5:766-72.
14. Janin-Mereier A, Devergie A, van Cauwenberg D, Saurat JH, Bourges M, Lapiere CM, et al. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man. Am J Pathol 1984;115:296-306.
15. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma: collagen. Rheum Dis Clin North Am 1996;22:647-74.
16. Silman AJ, Black CM, Welsh KI. Epidemiology, demographics, genetics. In: Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore: Williams and Wilkins; 1996. p. 23.
17. Medsger TA. Epidemiology of systemic sclerosis. Clin Dermatol 1994;12:207-16.
18. Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis 1998;47:441-4.
19. Steen VD, Conte C, Santoro D. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990;16:1-10.
20. Black CM, Stevens WM. Scleroderma. Rheum Dis Clin North Am 1989;15:193-212.
21. Mullimax F. Chimerism and autoimmunity. In: Feng PH, Boey ML, Chug HH, Fong KY, Howe HS, Leong KH, editors. Proceedings of the fourth ASEAN Congress of Rheumatology. Singapore: Communication Consultants; 1993. p. 34-40.
22. Bianchi DW, Kickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years. Proc Natl Acad Sci U S A 1996;93:705-8.
23. Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996;39:191-4.
24. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186-91.
25. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62.
26. Bunce M, O'Neill CM, Barnardo MCNM, Krausa P, Browning MJ, Morris PJ, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
27. Artlett CM, Black CM, Welsh KI, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997;47:17-22.
28. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Crileria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
31. Carter AS, Bunce M, Cerundolo L, Welsh K, Morris PJ, Fuggle SV. Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): a cautionary tale. Blood 1998;15:683-9.
32. Vaughan RW, Lanchbury JS, Marsh SG, Hall MA, Bodmer JG, Welsh KI. The application of oligonucleotide probes to HLA class II typing of the DRB sub-region. Tissue Antigens 1990;36:149-55.
33. Maloney S, Smith A; Furst DE, Myerson D, Rupert K, Evans PC, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999;104:41-7.
34. Appleton AL, Curtis A, Wilkes A, Cant AJ. Differentiation of materno-fetal GVHD from Omenn's syndrome in pre-BMT patients with severe combined immunodeficiency. Bone Marrow Transplant 1994;14:157-9.
35. Brubaker DB. Immunopathogenic mechanisms of posttransfusion graft-vs-host disease. Proc Soc Exp Biol Med 1993;202:122-47.
36. Juji T, Takahashi K, Shibata Y, Ide H, Sakakibara T, Ino T, et al. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan [letter]. N Engl J Med 1989;320:56.